These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27062639)

  • 21. Sharp bounds on causal effects using a surrogate endpoint.
    Kuroki M
    Stat Med; 2013 Nov; 32(25):4338-47. PubMed ID: 23754776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance.
    Little RJ; Long Q; Lin X
    Biometrics; 2009 Jun; 65(2):640-9. PubMed ID: 18510650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.
    Shen W; Ning J; Yuan Y
    Stat Med; 2015 Jun; 34(13):2104-15. PubMed ID: 25756852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Likelihood-based inference for bounds of causal parameters.
    Lee W; Sjölander A; Larsson A; Pawitan Y
    Stat Med; 2018 Dec; 37(30):4695-4706. PubMed ID: 30155912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of partial noncompliance on the power of a clinical trial.
    Freedman LS
    Control Clin Trials; 1990 Jun; 11(3):157-68. PubMed ID: 2163811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causal inference in paired two-arm experimental studies under noncompliance with application to prognosis of myocardial infarction.
    Bartolucci F; Farcomeni A
    Stat Med; 2013 Nov; 32(25):4348-66. PubMed ID: 23754710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment noncompliance in randomized experiments: statistical approaches and design issues.
    Sagarin BJ; West SG; Ratnikov A; Homan WK; Ritchie TD; Hansen EJ
    Psychol Methods; 2014 Sep; 19(3):317-33. PubMed ID: 24773358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The large sample bounds on the principal strata effect with application to a prostate cancer prevention trial.
    Chiba Y
    Int J Biostat; 2012 May; 8(1):Article 12. PubMed ID: 22628357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the causal effect of randomization versus treatment preference in a doubly randomized preference trial.
    Marcus SM; Stuart EA; Wang P; Shadish WR; Steiner PM
    Psychol Methods; 2012 Jun; 17(2):244-54. PubMed ID: 22563844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.